Granules India Limited
Kotak Mahindra Life Insurance bought 11,54,316 shares of Granules India for ₹100.71 Cr at ₹872.50 apiece in a block deal.
A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.
Wholly owned subsidiary of Kotak Mahindra Bank. Crossed Rs 1 lakh crore in AUM in November 2025, the 25th year of operations, with a 19% CAGR since 2010. CIO Radhavi Deshpande joined from Kotak Mahindra Bank's proprietary trading desk in April 2021 and runs a disciplined large and midcap equity book.